A Phase I Study of BR108 in Hematological Malignancies
BioRay Pharmaceutical Co., Ltd.
BioRay Pharmaceutical Co., Ltd.
Incyte Corporation
Hangzhou Sumgen Biotech Co., Ltd.
Fred Hutchinson Cancer Center
Celularity Incorporated
Fred Hutchinson Cancer Center
Antengene Corporation
Antengene Corporation
OHSU Knight Cancer Institute
Prelude Therapeutics
AstraZeneca
AbbVie
Fred Hutchinson Cancer Center
University of Chicago
Gilead Sciences
Acrotech Biopharma Inc.
M.D. Anderson Cancer Center
Cellectis S.A.
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Washington University School of Medicine
Celgene
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute
Sanofi
National Cancer Institute (NCI)
Myriad Therapeutics, Inc.